AMBU STRENGTHENS URETEROSCOPY PORTFOLIO WITH SUCTION ACCESS SHEATH
30.10.2026 10:04:25 CET | Ambu A/S | Press release
Ambu launches a new flexible and navigable suction access sheath (FANS), enabling a more complete ureteroscopy solution for urologists treating patients with kidney stones.
Copenhagen, Denmark, 30 October 2026 – Ambu, the global leader in single-use endoscopy, today announces an addition to its Urology portfolio: a flexible and navigable suction access sheath (FANS) designed for use with Ambu® aScope™ 5 Uretero during urolithiasis procedures (kidney stone removals).
Because every kidney stone procedure is unique, urologists need to maintain a clear field of view and manage irrigation throughout each case. Ambu’s FANS access sheath combines flexible navigation with continuous suction to remove fluid, stone fragments, and dust, helping urologists navigate challenging anatomy and support stone removal.
Adding FANS to its ureteroscopy portfolio enables Ambu to offer urologists a more comprehensive stone management solution, while helping unlock and capture more value per procedure. Further, this strengthens Ambu’s differentiated Urology offering, which includes high-quality single-use endoscopes, the Company's innovative EndoIntelligence™ technology platform, and complementary accessories.
“Our new flexible suction access sheath is another example of how we are expanding beyond the endoscope to build more complete and differentiated solutions for our customers,” says Britt Meelby Jensen, CEO of Ambu. “By bringing together our endoscopes, EndoIntelligence, and complementary accessories, we can create more value for healthcare partners and patients. This strengthens our position in Urology and advances single-use solutions as the standard of care in endoscopy.”
From November 2026, Ambu's FANS access sheath will be available in the U.S. and Europe. FANS is offered in two market-specific versions: an FDA-cleared version for the U.S. and a CE-marked version for Europe.
|
AMBU’S UROLOGY PORTFOLIO |
|
Ureteroscopy
Cystoscopy
EndoIntelligence™
|
Keywords
Contacts
Lisa Bedell CliveHead of Investor Relations
Tel:+44 7385 420133licl@ambu.comTine Bjørn SchmidtDirector of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comAbout Ambu
Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,500+ Ambu team members are committed to delivering above and beyond.
For more information, please visit Ambu.com.
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU EXTENDS RESPIRATORY OFFERING INTO PEDIATRIC AIRWAY PROCEDURES12.10.2026 12:39:52 CEST | Press release
Two bronchoscopes within the Ambu® aScope™ 5 Broncho portfolio have been cleared for pediatric use in the U.S. and Europe, extending Ambu’s Respiratory offering across both adult and pediatric patients.
AMBU APPOINTS BOARD OBSERVER, PLANS BOARD MEMBER NOMINATION28.9.2026 10:00:19 CEST | Press release
Current Grifols CEO and former Olympus executive, Nacho Abia, brings more than 20 years of leadership experience across global healthcare and endoscopy.
AMBU OBTAINS REGULATORY CLEARANCES FOR EXPANDED GI INDICATION25.9.2026 08:42:31 CEST | Press release
With an expanded indication for sigmoidoscopy procedures, Ambu® aScope™ Gastro and Ambu® aScope™ Gastro Large are the first single-use GI endoscopy solutions indicated for both upper and lower GI procedures, nearly doubling Ambu’s procedure reach in GI.
AMBU ACQUIRES TIMS MEDICAL TO ADVANCE ENDOINTELLIGENCE14.9.2026 15:00:00 CEST | Press release
The acquisition expands Ambu's endoscopy offering with established hospital integration and workflow technology and access to around 7,000 installations across U.S. hospitals, accelerating the Company's EndoIntelligence™ agenda.
AMBU EXPANDS NEUROLOGY PORTFOLIO IN NORTH AMERICA AND EUROPE20.8.2026 09:00:00 CEST | Press release
Ambu expands its neurology portfolio with an EEG solution that supports continued brain monitoring during MRI/CT scans, following FDA clearance and CE marking for Ambu® Neuroline™ Cup MRI/CT.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom